Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 446-240-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01-02-2000 to 21-02-2000
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline study performed under GLP. All relevant validity criteria were met with acceptable deviations.
- Remarks:
- The efficacy of the S9-mix was only validated using 2-Anthramine (2-Aminoanthracene CAS 613-13-8) and benzopyrene or dimethylbenzanthracene was not used in each test. This is reflected in the reliability score.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- The efficacy of the S9-mix was only validated using 2-Anthramine (2-Aminoanthracene CAS 613-13-8) and benzopyrene or dimethylbenzanthracene was not used in each test. This is reflected in the reliability score.
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Version / remarks:
- Notification No. 700 of the Environmental Agency, No. 1039 of the Ministry of Health and Welfare and No. 1014 of Ministry of International Trade and Industry, 09 December 1986
- Deviations:
- yes
- Remarks:
- see above
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- yes
- Remarks:
- see above
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- yes
- Remarks:
- see above
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- inspected: September 1999 ; signature: December 1999
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- -
- EC Number:
- 446-240-3
- EC Name:
- -
- Cas Number:
- 389083-83-4
- Molecular formula:
- C16H32O2
- IUPAC Name:
- (1-ethoxyethoxy)cyclododecane
- Test material form:
- liquid
- Details on test material:
- - Physical state: Liquid
- Storage condition of test material: At room temperature, protected from light and under nitrogen gas
- Other: colourless
Constituent 1
Method
- Target gene:
- histidine or tryptophan locus
Species / strainopen allclose all
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9
- Test concentrations with justification for top dose:
- Preliminary toxicity test (TA98, TA100 and Wp2urvA): 0, 10, 100, 500, 1000, 2500 and 5000 µg/plate with and without S9 mix
Experiment 1 (plate incorporation method): All strains: 0, 312.5, 625, 1250, 2500, 5000 µg/plate with and without S9 mix
Experiment 2 (preincubation method): All strains: 0, 312.5, 625, 1250, 2500, 5000 µg/plate with and without S9 mix - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol (batch number and supplier listed in full study report).
- Justification for choice of solvent/vehicle: Ethanol was selected as the vehicle. Test item was dissolved in the vehicle at a concentration of 100 mg/ml for the preliminary toxicity test and for both mutagenicity experiments. The preparations were made immediately before use.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- other: 2-Aminoanthracene (with S9)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Preliminary Toxicity Test: in medium; in agar (plate incorporation), Experiment 1. in medium; in agar (plate incorporation) ; Experiment 2. in medium; in agar (pre-incubation)
DURATION
- Exposure duration:
Preliminary Toxicity Test: To assess the toxicity of the test substance to the bacteria, at least six dose-levels (one plate/dose-level) will be tested in the TA98, TA100 and WP2uvrA strains, with and without S9 mix. Test item solution (0.05 mL), S9 mix (0.5 mL) when required and bacterial suspension (0.1 mL) were mixed with 2 mL of overlay agar (containing traces of the relevant amino acid and biotin and maintained at 45°C). After rapid homogenization, the mixture was overlaid onto a Petri plate containing minimum medium.
Experiment 1. Test item solution (0.05 mL), S9 mix (0.5 mL) when required and bacterial suspension (0.1 mL) were mixed with 2 mL of overlay agar (containing traces of the relevant amino acid and biotin and maintained at 45°C). After rapid homogenization, the mixture was overlaid onto a Petri plate containing minimum medium.
Experiment 2. Test item solution (0.05 mL), S9 mix (0.5 mL) and bacterial suspension (0.1 mL) were incubated for 60 minutes at 37°C before adding the overlay agar and pouring onto the surface of a minimum agar plate.
After 48 to 72 hours incubation at 37 ºC the revertants were scored using an automated colony counting system. The plates were viewed microscopically for evidence of thinning (toxicity).
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- Evidence leading to positive result:
1. Reproducible two-fold increase in the number of revertants compared with the vehicle controls, in any strain at any dose-level
2. Evidence of dose-relationship, in any strain
Reference to historical data and/or other considerations such as biological relevance would be taken into consideration during the evaluation of data
Applicant assessment indicates: The test item is considered non-mutagenic (negative) in the test system if the above criteria are not met. Instances of data prohibiting definitive judgement about test item activity may be reported as equivocal.
Acceptance Criteria:
The study is considered valid if the following criteria are met:
1. The number of revertants in the vehicle controls is consistent with the historical control data range (information attached to the full study report)
2. The number of revertants in the positive control is higher than the vehicle controls and consistent with the historical control range (information attached to the full study report).
Results and discussion
Test resultsopen allclose all
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- See table 1 and 2, without S9 mix activation, slight to moderate cytotoxicity was observed.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- See table 1 and 2, without S9 mix activation, slight to moderate cytotoxicity was observed.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
Any other information on results incl. tables
Table 1 : Test Results: Experiment 1 – Preliminary Toxicity Test : with and without metabolic activation and results of concurrent positive controls
Strains |
Doses µg/plate |
Without S9 Mix |
With S9 Mix |
||||
|
|
T |
E |
Revertants per plate |
T |
E |
Revertants per plate |
TA98 |
0 |
0 |
0 |
24 |
0 |
0 |
29 |
|
10 |
0 |
0 |
21 |
0 |
0 |
24 |
|
100 |
0 |
0 |
19 |
0 |
0 |
23 |
|
500 |
0 |
0 |
14 |
0 |
0 |
17 |
|
1000 |
0 |
0 |
19 |
0 |
0 |
38 |
|
2500 |
0 |
1 |
23 |
0 |
1 |
20 |
|
5000 |
0 |
2 |
10 |
0 |
1 |
20 |
|
|
|
|
|
|
|
|
TA100 |
0 |
0 |
0 |
82 |
0 |
0 |
95 |
|
10 |
0 |
0 |
71 |
0 |
0 |
104 |
|
100 |
0 |
0 |
61 |
0 |
0 |
84 |
|
500 |
0 |
0 |
43 |
0 |
0 |
83 |
|
1000 |
1 |
0 |
55 |
0 |
0 |
82 |
|
2500 |
1 |
1 |
65 |
0 |
1 |
90 |
|
5000 |
1 |
1 |
38 |
0 |
1 |
90 |
|
|
|
|
|
|
|
|
WP2 uvrA |
0 |
0 |
0 |
29 |
0 |
0 |
40 |
|
10 |
0 |
0 |
18 |
0 |
0 |
40 |
|
100 |
0 |
0 |
22 |
0 |
0 |
30 |
|
500 |
0 |
0 |
31 |
0 |
0 |
30 |
|
1000 |
0 |
0 |
25 |
0 |
0 |
22 |
|
2500 |
0 |
1 |
28 |
0 |
1 |
31 |
|
5000 |
0 |
1 |
21 |
0 |
1 |
34 |
|
|
|
|
|
|
|
|
0 = vehicle control (Ethanol)
Where:
T = toxicity : score = 0, none, 1 = slight, 2 = moderate, 3 = considerable to total
E = Emulsion of test item: score = 0, none, 1 = slight, 2 = moderate, 3 = strong
Table 2 : Test Results: Experiment 2 – Main Test (pre-incubation method) : with and without metabolic activation and results of concurrent positive controls
With S9 Mix |
||||||||
Strains |
Doses µg/plate |
T |
E |
Revertants per plate |
Mean |
Standard Deviation |
||
|
|
|
|
1 |
2 |
3 |
|
|
TA1535 |
0 |
0 |
0 |
29 |
30 |
26 |
28 |
2 |
|
312.5 |
0 |
0 |
25 |
13 |
30 |
23 |
9 |
|
625 |
0 |
0 |
23 |
24 |
27 |
25 |
2 |
|
1250 |
0 |
0 |
21 |
13 |
41 |
25 |
14 |
|
2500 |
0 |
0 |
20 |
31 |
25 |
25 |
6 |
|
5000 |
0 |
1 |
27 |
29 |
30 |
29 |
2 |
|
2AM(2) |
- |
- |
258 |
232 |
226 |
239 |
17 |
|
|
|
|
|
|
|
|
|
TA1537 |
0 |
0 |
0 |
6 |
10 |
7 |
8 |
2 |
|
312.5 |
0 |
0 |
8 |
4 |
8 |
7 |
2 |
|
625 |
0 |
0 |
13 |
7 |
7 |
9 |
3 |
|
1250 |
0 |
0 |
4 |
9 |
4 |
6 |
3 |
|
2500 |
0 |
0 |
15 |
8 |
7 |
10 |
4 |
|
5000 |
0 |
1 |
6 |
3 |
5 |
5 |
2 |
|
2AM(2) |
- |
- |
81 |
75 |
98 |
85 |
12 |
|
|
|
|
|
|
|
|
|
TA98 |
0 |
0 |
0 |
19 |
12 |
21 |
17 |
5 |
|
312.5 |
0 |
0 |
14 |
15 |
12 |
14 |
2 |
|
625 |
0 |
0 |
28 |
13 |
16 |
19 |
8 |
|
1250 |
0 |
0 |
21 |
16 |
17 |
18 |
3 |
|
2500 |
0 |
0 |
28 |
13 |
14 |
18 |
8 |
|
5000 |
0 |
1 |
24 |
12 |
18 |
18 |
6 |
|
2AM(2) |
- |
- |
1362 |
1317 |
1383 |
1354 |
34 |
|
|
|
|
|
|
|
|
|
TA100 |
0 |
0 |
0 |
139 |
132 |
114 |
128 |
13 |
|
312.5 |
0 |
0 |
92 |
81 |
93 |
89 |
7 |
|
625 |
0 |
0 |
93 |
111 |
91 |
98 |
11 |
|
1250 |
0 |
0 |
76 |
95 |
72 |
81 |
12 |
|
2500 |
0 |
0 |
80 |
74 |
77 |
77 |
3 |
|
5000 |
0 |
1 |
65 |
72 |
64 |
67 |
4 |
|
2AM(2) |
- |
- |
1087 |
992 |
921 |
1000 |
83 |
|
|
|
|
|
|
|
|
|
WP2 uvrA |
0 |
0 |
0 |
55 |
44 |
37 |
45 |
9 |
|
312.5 |
0 |
0 |
46 |
35 |
32 |
38 |
7 |
|
625 |
0 |
0 |
50 |
40 |
34 |
41 |
8 |
|
1250 |
0 |
0 |
39 |
26 |
44 |
36 |
9 |
|
2500 |
0 |
0 |
49 |
42 |
46 |
46 |
4 |
|
5000 |
0 |
1 |
39 |
32 |
38 |
36 |
4 |
|
2AM(10) |
- |
- |
233 |
170 |
179 |
194 |
34 |
|
|
|
|
|
|
|
|
|
Without S9 Mix |
||||||||
TA1535 |
0 |
0 |
0 |
6 |
10 |
12 |
9 |
3 |
|
312.5 |
0 |
0 |
5 |
5 |
5 |
5 |
0 |
|
625 |
0 |
0 |
7 |
8 |
6 |
7 |
1 |
|
1250 |
0 |
0 |
7 |
7 |
5 |
6 |
1 |
|
2500 |
0 |
0 |
13 |
7 |
7 |
9 |
3 |
|
5000 |
0 |
1 |
7 |
10 |
8 |
8 |
2 |
|
NaN3(1) |
- |
- |
646 |
616 |
703 |
655 |
44 |
|
|
|
|
|
|
|
|
|
TA1537 |
0 |
0 |
0 |
9 |
14 |
13 |
12 |
3 |
|
312.5 |
1 |
0 |
5 |
5 |
5 |
5 |
0 |
|
625 |
1 |
0 |
8 |
10 |
6 |
8 |
2 |
|
1250 |
2 |
0 |
11 |
7 |
8 |
9 |
2 |
|
2500 |
2 |
0 |
11 |
7 |
7 |
8 |
2 |
|
5000 |
2 |
1 |
9 |
6 |
5 |
7 |
2 |
|
9AA(50) |
- |
- |
332 |
287 |
435 |
351 |
76 |
|
|
|
|
|
|
|
|
|
TA98 |
0 |
0 |
0 |
17 |
16 |
15 |
16 |
1 |
|
312.5 |
0 |
0 |
11 |
13 |
10 |
11 |
2 |
|
625 |
0 |
0 |
18 |
10 |
14 |
14 |
4 |
|
1250 |
1 |
0 |
12 |
17 |
17 |
15 |
3 |
|
2500 |
1 |
0 |
22 |
14 |
18 |
18 |
4 |
|
5000 |
2 |
1 |
15 |
20 |
10 |
15 |
5 |
|
2NF(0.5) |
- |
- |
150 |
164 |
147 |
154 |
9 |
|
|
|
|
|
|
|
|
|
TA100 |
0 |
0 |
0 |
107 |
97 |
93 |
99 |
7 |
|
312.5 |
0 |
0 |
94 |
80 |
81 |
85 |
8 |
|
625 |
0 |
0 |
124 |
102 |
104 |
110 |
12 |
|
1250 |
0 |
0 |
83 |
77 |
88 |
83 |
6 |
|
2500 |
0 |
0 |
119 |
90 |
96 |
102 |
15 |
|
5000 |
0 |
1 |
106 |
96 |
76 |
93 |
15 |
|
NaN3(1) |
- |
- |
793 |
771 |
773 |
779 |
12 |
|
|
|
|
|
|
|
|
|
WP2 uvrA |
0 |
0 |
0 |
30 |
20 |
34 |
28 |
7 |
|
312.5 |
0 |
0 |
27 |
24 |
28 |
26 |
2 |
|
625 |
0 |
0 |
31 |
40 |
32 |
34 |
5 |
|
1250 |
0 |
0 |
35 |
27 |
28 |
30 |
4 |
|
2500 |
0 |
0 |
40 |
29 |
27 |
32 |
7 |
|
5000 |
0 |
1 |
27 |
25 |
23 |
25 |
2 |
|
4NQQ(2) |
- |
- |
1761 |
1781 |
1791 |
1778 |
15 |
|
|
|
|
|
|
|
|
|
0 = vehicle control (Ethanol)
Where:
T = toxicity : score = 0, none, 1 = slight, 2 = moderate, 3 = considerable to total
E = Emulsion of test item: score = 0, none, 1 = slight, 2 = moderate, 3 = strong
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
Negative
Under the conditions of this study the test item was considered to be non-mutagenic in the presence and absence of S9 activation. - Executive summary:
The study was performed to the requirements of OECD Guideline 471, Japanese guidelines for bacterial mutagenicity testing and EU Method B.14, under GLP, to evaluate the potential mutagenicity of the test item in a bacterial reverse mutation assay using S.typhimurium strains TA98, TA100, TA1535, TA1537 and E.coli strain WP2uvrA- in both the presence and absence of S-9 mix activation system. The test strains were treated in two independent experiments with the test item, utilising the Ames plate incorporation method and then preincubation method, respectively at up to five dose levels, in triplicate, both with and without the addition of a rat liver microsomal metabolic activation system (10% liver S9). The vehicle was ethanol. The dose range for Experiment 1 was predetermined based on the results of a preliminary toxicity assay. The evaluation of toxicity was performed on the basis of the observation of the decrease in the number of revertant colonies and/or a thinning of the bacterial lawn. The Experiment 1 dose levels were 312.5, 625, 1250, 2500 and 5000 µg/plate for all Salmonella strains: TA98, TA100, TA1535, TA1537 and for E.coli strain WP2uvrA-. The experiment was repeated using the same dose range by the pre-incubation method in Experiment 2. All of the positive controls used in the test induced expected increases in the frequency of revertant colonies, both with or without metabolic activation. The vehicle controls were considered acceptable. Therefore the assay was considered valid. The maximum dose level of the test item in the Experiment 1 and Experiment 2 was the maximum recommended dose level of 5000 μg/plate in all tester strains. A slight emulsion was observed in the plates when scoring the revertants mainly at the highest dose-level. Without S9 mix, a slight to moderate toxicity was generally induced, depending on the dose-levels and the tester strains. With S9 mix, except for a slight decrease in the number of revertants, noted in the second experiment (preincubation method) in the TA1537 and TA100 strains at the highest dose-level, no noteworthy toxicity was induced in both experiments. There were no significant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9 mix). It was concluded that, under the conditions of this assay, the test item gave a negative, i.e. non-mutagenic response in S.typhimurium strains TA98, TA100, TA1535, TA1537 and E.coli strain WP2uvrA- in the presence and absence of S-9 mix.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.